Boothbay Fund Management, LLC Oramed Pharmaceuticals Inc. Transaction History
Boothbay Fund Management, LLC
- $4.17 Billion
- Q1 2024
A detailed history of Boothbay Fund Management, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 689,749 shares of ORMP stock, worth $1.5 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
689,749
Previous 525,001
31.38%
Holding current value
$1.5 Million
Previous $1.21 Million
66.17%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ORMP
# of Institutions
59Shares Held
5.69MCall Options Held
8.3KPut Options Held
2.7K-
Murchinson Ltd. Toronto, A61.38MShares$3.01 Million0.36% of portfolio
-
Bml Capital Management, LLC Zionsville, IN844KShares$1.84 Million1.65% of portfolio
-
Morgan Jess S & CO Inc366KShares$798,7542.07% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA344KShares$750,8740.0% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$631,7700.01% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $84.6M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...